Trending
Revolutionary Shows Promise 4
Revolutionary Shows Promise 3
Revolutionary Shows Promise 1
Revolutionary aids Treatment Shows Promise
Revolutionary Cancer Treatment Shows Promise
FDA Expands Approval of Vonvendi for von Willebrand Disease, Including Pediatric Use
Child Depression Fluctuations may trigger Parent Depression not vice versa: JAMA
Indoor Air Quality and Diet Found to Regulate Inflammation in Childhood: Study Finds
How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out
Follow Us:
November 05, 2025

Get In Touch

Topical Cidofovir Therapy Effective In Clearing Cutaneous Warts Dermatology

Topical Cidofovir Therapy Effective In Clearing Cutaneous Warts

  • 18 July 2025
  • 3 months ago

Same-Day Combo Of Chemical Peels And Neurotoxins Safe And Effective Cosmetic Therapy For Photoaging Dermatology

Same-Day Combo Of Chemical Peels And Neurotoxins Safe And Effective Cosmetic Therapy For Photoaging

  • 18 July 2025
  • 3 months ago

Dupilumab Significantly Improves Itch And Hives In Chronic Spontaneous Urticaria Patients: Study Dermatology

Dupilumab Significantly Improves Itch And Hives In Chronic Spontaneous Urticaria Patients: Study

  • 18 July 2025
  • 3 months ago

Dupilumab Significantly Improves Sleep Quality And Other Signs And Symptoms In Atopic Dermatitis Patients Dermatology

Dupilumab Significantly Improves Sleep Quality And Other Signs And Symptoms In Atopic Dermatitis Patients

  • 18 July 2025
  • 3 months ago

Lebrikizumab Effectively Improves Moderate To Severe Atopic Dermatitis In Phase 3 Trial Dermatology

Lebrikizumab Effectively Improves Moderate To Severe Atopic Dermatitis In Phase 3 Trial

  • 18 July 2025
  • 3 months ago

HPPF Quick And Effective Way Fy Achieving Hemostasis After Punch Biopsies: Study Dermatology

HPPF Quick And Effective Way Fy Achieving Hemostasis After Punch Biopsies: Study

  • 18 July 2025
  • 3 months ago

Adolescents With Atopic Dermatitis Experience Greater Burden Of Bullying: JAMA. Dermatology

Adolescents With Atopic Dermatitis Experience Greater Burden Of Bullying: JAMA.

  • 18 July 2025
  • 3 months ago

Cendakimab Effective, Safe, And Well-Tolerated In Patients With Moderate To Severe Atopic Dermatitis: JAMA Dermatology

Cendakimab Effective, Safe, And Well-Tolerated In Patients With Moderate To Severe Atopic Dermatitis: JAMA

  • 18 July 2025
  • 3 months ago

Risankizumab Effective In Moderate-To-Severe Plaque Psoriasis With Favourable Safety Profile Laboratory Medicine

Risankizumab Effective In Moderate-To-Severe Plaque Psoriasis With Favourable Safety Profile

  • 18 July 2025
  • 3 months ago

HSP90 Inhibition Novel Mechanism For Treating Hidradenitis Suppurativa: JAMA Dermatology

HSP90 Inhibition Novel Mechanism For Treating Hidradenitis Suppurativa: JAMA

  • 18 July 2025
  • 3 months ago

Recent News

HC pulls up NMC for not filing reply in FMG Intern...

  • 04 November, 2025

Eli Lilly plans to build new USD 3 billion facilit...

  • 04 November, 2025

Rajkot Maternity Hospital CCTV Leak: How a simple...

  • 04 November, 2025

Gland Pharma profit rises 12 percent to Rs 184 cro...

  • 04 November, 2025

AIIMS Delhi doctors told to use Hindi in prescript...

  • 04 November, 2025

Daily Newsletter

Get all the top stories from Blogs to keep track.